| Palomar sues Candela over patents
In the lawsuit, filed in the U.S. District Court in Massachusetts, Palomar said Candela\'s light-based hair removal systems, including GentleLas and GentleYag, infringe on patents it has exclusively licensed from General Hospital Corp. Palomar is seeking monetary damages and an injunction against further infringement by the Wayland, Mass.-based Candela. \"For over seven years, Palomar has sent Candela letters notifying Candela that its products need a license to the \'844 Patent and offering to grant Candela such a license,\" said Patricia Davis, the company\'s general counsel. Candela could not be immediately reached for comment. Palomar favorably settled a similar suit in June against Cutera Inc., which also makes skin laser treatments. Shares of Palomar fell 75 cents, or 2.1 percent, to $34.44 in morning trading on the Nasdaq, while Candela Corp.\'s stock dropped $1.40, or 9.5 percent, to $13.36 on the Nasdaq.
The science of facial rejuvenation
August 16, 2006 You cant judge a book by its cover, but you can certainly take a good guess at when it was printed, and with the wealthiest generation in history heading for old age, its not surprising that massive effort is being focussed on anti-aging technologies. Since 1997 there has been a five-fold increase in the number of cosmetic procedures in the United States, with 11.5 million performed last year. The numbers are quite remarkable over 90% of procedures were performed on women, and a similar percentage were focussed on the face the cover that is obviously being adjudged too old: last year 3.3 million people had Botox injections, 1.6 million had Laser hair removal, 1.2 million had Hyaluronic acid treatments, 1.0 million had dermabrasion, 556,000 had chemical peels, 231,000 had Blepharoplasty (cosmetic eyelid surgery) and 201,000 had nose jobs (Rhinoplasty).
|